|
TMEM70 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.096400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.933720E-02 |
| Normal-vs-Stage2 |
3.879200E-01 |
| Normal-vs-Stage3 |
1.786580E-01 |
| Normal-vs-Stage4 |
9.230200E-01 |
| Stage1-vs-Stage2 |
4.209600E-01 |
| Stage1-vs-Stage3 |
6.082300E-02 |
| Stage1-vs-Stage4 |
3.919600E-01 |
| Stage2-vs-Stage3 |
1.160200E-01 |
| Stage2-vs-Stage4 |
5.571400E-01 |
| Stage3-vs-Stage4 |
2.591400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.636000E-02 |
| Normal-vs-AfricanAmerican |
6.468200E-01 |
| Normal-vs-Asian |
2.360800E-01 |
| Caucasian-vs-AfricanAmerican |
4.983400E-01 |
| Caucasian-vs-Asian |
1.949640E-01 |
| AfricanAmerican-vs-Asian |
2.212200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.341990E-01 |
| Normal-vs-Female |
8.986400E-01 |
| Male-vs-Female |
4.151000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.467200E-01 |
| Normal-vs-Extreme_Weight |
7.905800E-01 |
| Normal-vs-Obese |
1.825250E-01 |
| Normal-vs-Extreme_Obese |
3.463600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.974800E-01 |
| Normal_Weight-vs-Obese |
8.465600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.086800E-01 |
| Extreme_Weight-vs-Obese |
4.021400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.420600E-01 |
| Obese-vs-Extreme_Obese |
8.408600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.497400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.134600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.742300E-02 |
| Normal-vs-Age(81-100Yrs) |
6.890800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.584600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.495000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.776200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.645600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.897400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.038000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.967500E-02 |
| Normal-VS-Type2 PRCC |
4.571400E-01 |
| Normal-VS-KIRP CIMP |
4.812600E-01 |
| Normal-VS-Unclassified PRCC |
1.001810E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.133760E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.417000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.391000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.998600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.227600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.839800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.066000E-01 |
| Normal-vs-N1 |
2.627600E-01 |
| Normal-vs-N2 |
1.053030E-01 |
| N0-vs-N1 |
4.509800E-01 |
| N0-vs-N2 |
6.129400E-01 |
| N1-vs-N2 |
1.200550E-01 |
|
|
